Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Epigallocatechin-3-gallate, an active green tea component to support anti-VEGFA therapy in wet age-related macular degeneration
J Blasiak, J Chojnacki, J Szczepanska, M Fila… - Nutrients, 2023 - mdpi.com
Age-related macular degeneration (AMD) is a largely incurable disease and an emerging
problem in aging societies. It occurs in two forms, dry and wet (exudative, neovascular) …
problem in aging societies. It occurs in two forms, dry and wet (exudative, neovascular) …
[HTML][HTML] Immunoregulation mechanism of VEGF signaling pathway inhibitors and its efficacy on the kidney
J Li, XL Li, CQ Li - The American Journal of the Medical Sciences, 2023 - Elsevier
Angiogenesis and immunosuppression are closely related pathophysiologic processes.
Widely prescribed in malignant tumor and proliferative retinal lesions, VEGF signaling …
Widely prescribed in malignant tumor and proliferative retinal lesions, VEGF signaling …
Thrombotic microangiopathy syndromes—Common ground and distinct frontiers
Thrombotic microangiopathies (TMAs) have in common a terminal phenotype of
microangiopathic hemolytic anemia with end-organ dysfunction. Thrombotic …
microangiopathic hemolytic anemia with end-organ dysfunction. Thrombotic …
Unbiased analysis of temporal changes in immune serum markers in acute COVID-19 infection with emphasis on organ failure, anti-viral treatment, and demographic …
K Laudanski, H Jihane, B Antalosky, D Ghani… - Frontiers in …, 2021 - frontiersin.org
Identification of novel immune biomarkers to gauge the underlying pathology and severity of
COVID-19 has been difficult due to the lack of longitudinal studies. Here, we analyzed serum …
COVID-19 has been difficult due to the lack of longitudinal studies. Here, we analyzed serum …
Drug-induced glomerular diseases
AS Garnier, H Laubacher, M Briet - Therapies, 2024 - Elsevier
Drug-induced kidney diseases represent a wide range of diseases that are responsible for a
significant proportion of all acute kidney injuries and chronic kidney diseases. In the present …
significant proportion of all acute kidney injuries and chronic kidney diseases. In the present …
Biocompatible Macroion/Growth Factor Assemblies for Medical Applications
Growth factors are a class of proteins that play a role in the proliferation (the increase in the
number of cells resulting from cell division) and differentiation (when a cell undergoes …
number of cells resulting from cell division) and differentiation (when a cell undergoes …
Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration
Intravitreal vascular endothelial growth factor (VEGF) receptor blockade is used for a variety
of retinal pathologies. These include age-related macular degeneration (AMD), diabetic …
of retinal pathologies. These include age-related macular degeneration (AMD), diabetic …
[HTML][HTML] MicroRNAs as biomarkers and therapeutic targets for acute kidney injury
K Tsuji, H Nakanoh, K Fukushima, S Kitamura, J Wada - Diagnostics, 2023 - mdpi.com
Acute kidney injury (AKI) is a clinical syndrome where a rapid decrease in kidney function
and/or urine output is observed, which may result in the imbalance of water, electrolytes and …
and/or urine output is observed, which may result in the imbalance of water, electrolytes and …
Effect modification by indication to the risks of major thromboembolic adverse events in patients receiving intravitreal anti-vascular endothelial growth factor treatment …
Background The association between intravitreal anti-vascular endothelial growth factor
(anti-VEGF) treatment and the risk of major thromboembolic adverse events (TAEs) remains …
(anti-VEGF) treatment and the risk of major thromboembolic adverse events (TAEs) remains …
Nephrotoxicity from molecularly targeted chemotherapeutic agents
J Kala, LA Salman, AS Geara, H Izzedine - Advances in Chronic Kidney …, 2021 - Elsevier
The introduction of novel molecularly targeted therapies in the last 2 decades has
significantly improved the patient survival compared to standard conventional …
significantly improved the patient survival compared to standard conventional …